Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SCA3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
A gene referenced in 123 knowledge graph relationships. Key connections: participates_in oxidative stress response (pathway); associated_with Ataxia (disease); activates neurodegeneration (disease).
No AI portrait yet
| Gene Symbol | SCA3 |
| Full Name | ATXN3 (Ataxin-3) |
| Chromosome | 14q32.1. |
| Function | is a 361-amino acid protein encoded by the ATXN3 gene located on chromosome 14q32. |
| Amino Acids | 361 aa |
| UniProt ID | [Q9UHD8](https://www.uniprot.org/uniprotkb/Q9UHD8/entry) |
| GeneCards | SCA3 |
| Human Protein Atlas | SCA3 |
| N-terminal Josephin domain (JD) | A catalytic domain with deubiquitinating enzyme (DUB) activity |
| C-terminal polyglutamine (polyQ) tract | The pathogenic expansion occurs in this region |
| Multiple VCP/p97 binding motifs (VBM) | Involved in protein quality control |
| Nuclear localization signals (NLS) | Regulates subcellular trafficking |
| Protein quality control | Removing ubiquitin from misfolded proteins for degradation |
| Transcriptional regulation | Modulating histone ubiquitination |
| Stress response | Processing ubiquitin conjugates during cellular stress |
| Associated Diseases | Ataxia, Huntington, Huntington's disease, Ms, neurodegeneration |
| Interactions | ATM, ATXN3, CACNA1A, DNA, G3BP1, PNKP |
| KG Connections | 119 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
CAG["CAG Repeat Expansion"]
ATXN3["Mutant Ataxin-3"]
POLYQ["Polyglutamine Expansion"]
MISFOLD["Protein Misfolding"]
UPS["Ubiquitin Proteasome Stress"]
INCL["Nuclear Inclusions"]
TRANS["Transcription Dysregulation"]
MITO["Mitochondrial Dysfunction"]
OX["Oxidative Stress"]
PURK["Purkinje Neuron Loss"]
ATAX["Spinocerebellar Ataxia"]
AUTO["Autophagy Enhancement Target"]
CAG -->|"encodes"| ATXN3
ATXN3 -->|"contains"| POLYQ
POLYQ -->|"causes"| MISFOLD
MISFOLD -->|"burdens"| UPS
MISFOLD -->|"forms"| INCL
INCL -->|"disrupts"| TRANS
TRANS -->|"impairs"| MITO
MITO -->|"raises"| OX
OX -->|"damages"| PURK
PURK -->|"causes"| ATAX
AUTO -->|"clears"| MISFOLD
AUTO -->|"reduces"| OX| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:SCA3 | data_in | dataset_row | 0.00 |
| oxidative stress response | participates_in | pathway | 0.80 |
| Ataxia | associated_with | disease | 0.75 |
| VCP | interacts_with | gene | 0.70 |
| neurodegeneration | activates | disease | 0.70 |
| Neurodegeneration | implicated_in | disease | 0.65 |
| Neurodegeneration | regulates | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Ataxia | causes | disease | 0.65 |
| Spinocerebellar Ataxia | causes | disease | 0.65 |
| Neurodegeneration | biomarker_for | disease | 0.65 |
| Aging | biomarker_for | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Oligodendrocyte | associated_with | cell_type | 0.60 |
| Neuron | associated_with | cell_type | 0.60 |
| DNAJB1 | regulates | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| ATXN3 | therapeutic_target | gene | 0.60 |
| Huntington's disease | associated_with | disease | 0.60 |
| PROTEIN MISFOLDING | associated_with | gene | 0.60 |
| AUTOPHAGY | regulates | gene | 0.60 |
| HUNTINGTON | therapeutic_target | gene | 0.60 |
| PARKINSON | therapeutic_target | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| Neuron | therapeutic_target | cell_type | 0.60 |
| Oligodendrocyte | therapeutic_target | cell_type | 0.60 |
| App | therapeutic_target | protein | 0.60 |
| Oxidative Stress | biomarker_for | pathway | 0.60 |
| App | biomarker_for | protein | 0.60 |
| Huntington's disease | causes | disease | 0.60 |
| oligodendrocytes | expressed_in | cell_type | 0.60 |
| neurons | expressed_in | cell_type | 0.60 |
| autophagy pathway | participates_in | pathway | 0.60 |
| ubiquitin-proteasome | participates_in | pathway | 0.60 |
| Huntington's disease | interacts_with | disease | 0.60 |
| T cells | expressed_in | cell_type | 0.60 |
| neurodegeneration | causes | disease | 0.60 |
| neurodegeneration | regulates | disease | 0.60 |
| VCP | protects_against | gene | 0.60 |
| RAB7 | implicated_in | gene | 0.60 |
| SPG7 | regulates | gene | 0.60 |
| SCA7 | co_expressed_with | gene | 0.60 |
| SPG7 | co_expressed_with | gene | 0.60 |
| VCP | expressed_in | gene | 0.60 |
| neurodegeneration | interacts_with | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:SCA3 | data_in | dataset_row | 0.00 |
| ATXN3 | activates | gene | 0.70 |
| ATXN2 | causes | gene | 0.60 |
| G3BP1 | activates | gene | 0.60 |
| G3BP1 | protects_against | gene | 0.60 |
| G3BP1 | regulates | gene | 0.60 |
| G3BP1 | associated_with | gene | 0.60 |
| CACNA1A | activates | gene | 0.60 |
| ATM | activates | gene | 0.60 |
| PNKP | activates | gene | 0.60 |
| ATXN3 | protects_against | gene | 0.60 |
| CST3 | associated_with | gene | 0.60 |
| NEURODEGENERATION | regulates | gene | 0.60 |
| OLIGODENDROCYTE | associated_with | gene | 0.60 |
| HSPA1A | regulates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| ATXN3 | associated_with | gene | 0.60 |
| ATXN3 | regulates | gene | 0.60 |
| ATXN3 | interacts_with | gene | 0.60 |
| OXIDATIVE STRESS | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| CYCS | associated_with | gene | 0.60 |
| SOD1 | associated_with | gene | 0.60 |
| P62 | associated_with | gene | 0.60 |
| UBC | associated_with | gene | 0.60 |
| ATG3 | associated_with | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| ATG5 | implicated_in | gene | 0.60 |
| RAB5 | implicated_in | gene | 0.60 |
| ATG1 | implicated_in | gene | 0.60 |
| TNFRSF13C | associated_with | gene | 0.60 |
| RAN | associated_with | gene | 0.60 |
| LC3B | associated_with | gene | 0.60 |
| GAIN | regulates | gene | 0.60 |
| TNFRSF13C | encodes | gene | 0.60 |
| NFL | associated_with | gene | 0.60 |
| ATXN3 | causes | gene | 0.60 |
| ATXN3 | expressed_in | gene | 0.60 |
| ENDOSOME | associated_with | gene | 0.60 |
| NEURODEGENERATION | implicated_in | gene | 0.60 |
| ENDOSOMES | associated_with | gene | 0.60 |
| Neurodegeneration | regulates | disease | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SCA3 in their description or question text
No additional research found